Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Genetic analysis of systemic autoimmunity

Loading...
Thumbnail Image

Date

Authors

Garcia De Vinuesa, Maria Carola
Cook, Matthew

Journal Title

Journal ISSN

Volume Title

Publisher

John Wiley & Sons Inc

Abstract

Even for complex diseases with high rates of monozygotic twin concordance, disease-associated alleles remain elusive. One explanation is that multiple common genetic variants with weak effects cause these diseases and identification of any single allele requires large cohorts. Conversely, if the allelic spectrum of complex disease is heterogeneous, strong effects of rare variants might be offset by their presence in only a small proportion of the patient population. Lupus (SLE) is a systemic autoimmune disease, with significant monozygotic twin concordance, protean clinical manifestations, and production of high-affinity pathogenic autoantibodies. This complex phenotype and results from genome scans point to multiple molecular defects. Contrary to this expectation, our analysis of ENU-mutagenized mice indicates that homozygous mutations frequently cause anti-nuclear antibodies (ANAs), and can account for a full blown lupus phenotype. The best characterized example is the sanroque strain, which develops high-affinity dsDNA autoantibodies and fails to censor self-reactive germinal centre T cells. Mapping the underlying mutation identified not only a novel gene, Roquin, but also a novel pathogenic pathway for SLE. Identification of such rare variants with strong effects is likely to identify pathogenic pathways that underlie pathology in many patients, lead to interacting molecular partners that also cause pathology, and identify the most effective therapeutic targets.

Description

Citation

Source

Book Title

Decoding the genomic control of immune reactions: Novartis Foundation Symposium, No 281

Entity type

Access Statement

License Rights

DOI

Restricted until

2037-12-31
abcd